Bejescin (obinutuzumab-β) - Beijing Mabworks Biotech
Gazyva (obinutuzumab) - Roche, Biogen
http://clinicaltrials.gov/ct2/show/NCT07746180
 
Sep 16, 2026
 
Prev Next